A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: The DECODE study

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 5, 2008, Pages 591-600

  Chan, Charles ^a,h   Zambahari, Robaayah ^b   Kaul, Upendra ^c,k   Lau, C P ^d   Whitworth, Hall ^e   Cohen, Sidney ^f   Buchbinder, Maurice ^a,g   Carrozza, J ⁱ   Kalarickal, M S ^j   Metha, A B ^l   Rutherford, B ^m   Seth, A ⁿ  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b NATIONAL HEART INSTITUTE   (Malaysia)

^c FORTIS HOSPITAL   (India)

^d QUEEN MARY HOSPITAL   (Hong Kong)

^e FLORIDA HOSPITAL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Foundation for Cardiovascular Medicine   (United States)

^h GLENEAGLES HOSPITAL   (Singapore)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j APOLLO HOSPITALS   (India)

^k Batra Hospital and Research Centre   (India)

^l JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^m ST LUKE S HOSPITAL   (United States)

ⁿ Escorts Heart Institute and Research Centre   (India)

more..

Author keywords

Coronary artery disease; Coronary stenosis; Diabetes mellitus; Drug eluting stent; Myocardial revascularization

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; INSULIN; ORAL ANTIDIABETIC AGENT; RAPAMYCIN; CARDIOVASCULAR AGENT; FIBRINOLYTIC AGENT; METAL;

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; ARTICLE; ASIAN; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; UNITED STATES; AGED; ASIA; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; INSTRUMENTATION; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS; RADIOGRAPHY; RESTENOSIS; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIA; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; METALS; MIDDLE AGED; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 58749108849     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21719     Document Type: Article

References (26)

1. Morgan KP, Kapur A, Beutt KJ. Anatomy of coronary disease in diabetic patients: An explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 2004;90:732-738.
2. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengtson JR, Nelson CL, Tcheng JE, Mark DB, Stack RS. Restenosis after coronary angioplasty: An overview. J Am Coll Cardiol 1991;17:2B-13B.
3. Carrozza JP, Kuntz KE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993;118:344-349.
4. Chychota MN, Gan GT, Pluth JR, Wallace RB, Danielson GK. Myocardial revascularization: Comparison of operability and surgical results in diabetic and nondiabetic patients. J Thorac Cardiovasc Surg 1973;65:856-862.
5. Verska JJ, Walker WJ. Aortocoronary bypass in the diabetic patient. Am J Cardiol 1975;35:774-777.
6. Kip K, Faxon D, Detre K, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients (PTCA): The NHLBI PTCA Registry. Circulation 1996;94:1818-1825.
7. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB III. Influence of diabetes on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995; 91:979-989.
8. Abizaid A. Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Hongsheng W, Popma JJ, Leon MB. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589.
9. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-2556.
10. Weintraub WS, Stein B, Kosinski A, Douglas JS Jr, Ghazzal ZM, Jones EL, Morris DC, Guyton RA, Craver JM, King SB III. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998;31:10-19.
11. King SB III, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-1121.
12. Abizaid A, Costa MA, Centemero M, Abizaid AS, Legrand VM, Limet RV, Schuler G, Mohr FW, Lindeboom W, Sousa AG, Sousa JE, van Hout B, Hugenholtz PG, Unger F, Serruys PW. Arterial revascularization therapy study group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 2001;104:533-538.
13. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, Tryzelaar JF, Clough R, Hearne MJ, Hernandez F Jr, Watkins MW, O'Connor GT. Northern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: Results of a large regional prospective study. Northern New England cardiovascular disease study group. J Am Coll Cardiol 2001;37:1008-1015.
14. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-1129.
15. Legrand VM, Serruys PW, Unger F, van Hout BA, Vrolix MC, Fransen GM, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz e Melo JM, Neves JP, Lindeboom W, Backx B. Arterial Revascularization Therapy Study (ARTS) Investigators. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004;109:1114-1120.
16. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug-eluting stents: An updated meta-analysis of randomized controlled trials. Heart 2006;92:641-649.
17. Kastrati A, Dibra A, Eberle S, Mehilli J, Suares de Lezo J, Goy JJ, Ulm K, Schomig A. Sirolimus-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials. JAMA 2005;294:819-825.
18. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
19. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS Substudy. Circulation 2004;109: 2273-2278.
20. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
21. Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P. Efficacy of drug-eluting stents in patients with and without diabetes mellitus: Indirect comparison of controlled trials. Heart 2006;92:650-657.
22. Finn AV, Palacios IF, Kastrati A, Gold HK. Drug-eluting stents for diabetes mellitus: A rush to judgment? J Am Coll Cardiol 2005;45:479-483.
23. Sabaté M, Jiménez-Quevedo P, Angiolillo D, Gómez-Hospital J, Alfonso F, Hernandez-Antolín R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernandez C, Fernández-Avilés F, Macaya C; DIABETES Investigators. Randomised comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-2183.
24. Campeau L. Grading for angina pectoris [Letter]. Circulation 1976;54:522-523.
25. Braunwald E. Unstable angina. A classification. Circulation 1989;80:410-414.
26. Shuchman M. Trading restenosis for thrombosis? New questions about drug eluting stents. N Engl J Med 2006;355:1949-1952.